| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/03/2006 | WO2006065821A3 Improved dna immunization with recombinase/transposase |
| 08/03/2006 | WO2006060332A3 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 08/03/2006 | WO2006055871A3 Treatment for multiple sclerosis |
| 08/03/2006 | WO2006052926A3 Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and and cell death |
| 08/03/2006 | WO2006045532A3 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 08/03/2006 | WO2006041978A3 Multivalent avian influenza vaccines |
| 08/03/2006 | WO2006037660A3 Diagnosis and therapy of cell proliferative disorders characterized by resistance to trail induced apoptosis |
| 08/03/2006 | WO2006037038B1 Optimized vaccines to provide protection against ebola and other viruses |
| 08/03/2006 | WO2006026667A3 Recombinant mva viruses expressing glade a/g, clade b, and clade c modified hiv, gag and pol genes |
| 08/03/2006 | WO2006016930A3 Methods for treating hcv infection |
| 08/03/2006 | WO2006015371A3 Humanized anti-cmet antagonists |
| 08/03/2006 | WO2005116655A3 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | WO2005110470A3 Methods and compositions for the modulation of immune responses and autoimmune diseases by activating rp105 (cd180) |
| 08/03/2006 | WO2005110452A3 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFα-RELATED DISORDERS |
| 08/03/2006 | WO2005108428A3 Cd40 splice variants and their uses |
| 08/03/2006 | WO2005091753A3 Flexible vaccine assembly and vaccine delivery platform |
| 08/03/2006 | WO2005085288A3 Natural igm antibodies and inhibitors thereof |
| 08/03/2006 | WO2005070453A8 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 08/03/2006 | WO2005058474A9 Cryogranulation and storage method for active pharmaceutical agents |
| 08/03/2006 | WO2005049651A3 Cancer diagnosis and therapy |
| 08/03/2006 | WO2005041862A3 Neutralizing antibodies against extracellular hexosaminidase for treatment of arthritis |
| 08/03/2006 | WO2005016226A3 Pharmaceutical compositions comprising ccr5 antagonists |
| 08/03/2006 | WO2004058171A3 Antibodies against gpr64 and uses thereof |
| 08/03/2006 | WO2004001381A8 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/03/2006 | WO2003013425A3 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 08/03/2006 | US20060173171 Techniques and compositions for diagnosis and treatment of cancer (muci) |
| 08/03/2006 | US20060172966 Immunostimulatory G, U-containing oligoribonucleotides |
| 08/03/2006 | US20060172943 Restoring vascular function |
| 08/03/2006 | US20060172941 Antiproliferative agents; prevent binding of rndothelial growth factor to receptor; anticancer agents; leukemia; antiinflammatory agents; skin disorders |
| 08/03/2006 | US20060172933 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | US20060172930 Apoptosis-inducing gene and utilization of the same |
| 08/03/2006 | US20060172921 Method for identifying active anti-apoptosis compounds |
| 08/03/2006 | US20060172355 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172354 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172352 Nuclear matrix proteins |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172347 Method of diagnosis, treatment and useful agents for conditions characterised by modulation in the level of activin ssc |
| 08/03/2006 | US20060172301 Secreted acid phosphatse (sapm) is present only in pathogenic mycobacteria and expressed selectively at phagosomal ph |
| 08/03/2006 | US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 08/03/2006 | US20060172288 methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; provides for reovirus treatment of mammals to treat proliferative disorders including breast tumors, a subset of tumors in which mutation of ras gene is not believed to play significant role |
| 08/03/2006 | US20060172287 Murine calicivirus |
| 08/03/2006 | US20060172011 Medical treatment |
| 08/03/2006 | US20060171988 Method of treatment using foams as artificial lymph nodes |
| 08/03/2006 | US20060171984 Device having hydration inhibitor |
| 08/03/2006 | US20060171968 Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine |
| 08/03/2006 | US20060171967 Means and methods for diagnosing a treponema infection |
| 08/03/2006 | US20060171966 Variants of vibrio cholerae 01 biotype e1 tor with attributes of classical biotype |
| 08/03/2006 | US20060171965 Fusion proteins of mycobacterium tuberculosis |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | US20060171963 In situ administering to nerve endings by injection or topical |
| 08/03/2006 | US20060171962 SARS vaccine |
| 08/03/2006 | US20060171961 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 08/03/2006 | US20060171960 Methods and composition for oral vaccination |
| 08/03/2006 | US20060171959 Virulence genes, proteins, and their use |
| 08/03/2006 | US20060171957 Polypeptide-vaccines for broad protetion against hypervirulent meningococcal lineages |
| 08/03/2006 | US20060171956 Sphingoid polyalkylamine conjugates for hepatitis B virus vaccination |
| 08/03/2006 | US20060171955 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 08/03/2006 | US20060171954 Antigen specific activated T-lymphocytes, detection and use |
| 08/03/2006 | US20060171953 Tumour-specific animal proteins |
| 08/03/2006 | US20060171952 JAM-3 and antibodies that bind thereto |
| 08/03/2006 | US20060171951 Monoclonal antibodies that bind to antigen oncostatin M receptor beta subunit (OSM-R.beta); cancers |
| 08/03/2006 | US20060171950 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/03/2006 | US20060171949 Combination cancer immunotherapy with co-stimulatory molecules |
| 08/03/2006 | US20060171948 Methods of using IL-1 antagonists to reduce C-reactive protein |
| 08/03/2006 | US20060171947 Serine/threonine hydrolase proteins and screening assays |
| 08/03/2006 | US20060171946 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 08/03/2006 | US20060171945 Ip receptor antagonists for the treatment of pathological uterine conditions |
| 08/03/2006 | US20060171944 N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response |
| 08/03/2006 | US20060171943 Compositions and methods of treating fibrotic disorders |
| 08/03/2006 | US20060171942 Modified fusion molecules for treatment of allergic disease |
| 08/03/2006 | US20060171941 Humanized anti-TAG-72 CC49 monoclonal antibodies; retain binding affinity for TAG-72 and have reduced immunogenicity, as compared to a parental HuCC49V10 antibody; carcinoma; antitumor agent |
| 08/03/2006 | US20060171940 Antibody disulfide isomers, use thereof, and methods of analyzing same |
| 08/03/2006 | US20060171931 Modulators of Wnt signalling pathways and screening methods to identify them; muscular dystrophy; inhibitors of soluble Frizzled-related proteins |
| 08/03/2006 | US20060171929 Regulation of dendritic cell functions by the DCAL-2 receptor |
| 08/03/2006 | US20060171922 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 08/03/2006 | US20060171917 Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents |
| 08/03/2006 | US20060171899 Water-stabilized aerosol formulation system and method of making |
| 08/03/2006 | US20060171884 Provide a higher affinity towards Matriptase; have a very low, or nonmeasurable, immunogenicity in humans |
| 08/03/2006 | DE19632862B4 Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding therefor and the use thereof in test kits and as vaccines |
| 08/03/2006 | CA2606349A1 Immunologically active compositions |
| 08/03/2006 | CA2600111A1 Agent for stimulating the production of a blood coagulation factor viii |
| 08/03/2006 | CA2596920A1 Adjuvant for the enhancement of the efficacy of vaccines |
| 08/03/2006 | CA2596537A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | CA2595913A1 Oral vaccines for fish |
| 08/03/2006 | CA2595726A1 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin |
| 08/03/2006 | CA2595380A1 Stabilized liquid polypeptide formulations |
| 08/03/2006 | CA2593115A1 Dcchol for newborns |
| 08/03/2006 | CA2590974A1 Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/03/2006 | CA2590164A1 Antibodies against interleukin-1 beta |
| 08/03/2006 | CA2589860A1 Humanized anti-amyloid antibody |
| 08/03/2006 | CA2589556A1 Use of flagellin in tumor immunotherapy |
| 08/03/2006 | CA2567789A1 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 08/02/2006 | EP1686175A2 Proteins and nucleic acids encoding same |
| 08/02/2006 | EP1685848A1 Oral vaccines for fish |
| 08/02/2006 | EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine |
| 08/02/2006 | EP1685844A2 Immunostimulation by chemically modified RNA |
| 08/02/2006 | EP1685405A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 08/02/2006 | EP1685376A2 Viral fibers |
| 08/02/2006 | EP1685243A2 Immortalized avian cell lines for virus production |
| 08/02/2006 | EP1685236A2 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |